drugset / Trial / NCT07082816
Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Timeline
- Start
- 2025-09-02
- Primary completion
- 2026-04-06
- Completion
- 2026-04-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution | Unknown | 0.01 % | Topical |
| Subject | Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution | Unknown | 0.02 % | Topical |